Search GLEAM-DB / CoGenEx-PM3
Advanced search and filters
Input query
Recognized gene
ACADM, AGL, AHI1, ANK3, AP3D1 and 36 more
Normalized c.HGVS
c.*1243G>C, c.*893T>G, c.1079A>T, c.1090G>T, c.1184A>C and 41 more
Normalized p.HGVS
p.(=), p.(Ala151Thr), p.(Ala3Val), p.(Ala89Gly), p.(Arg103His) and 40 more
Matching records
2691
PM3-positive records
15
Results are ordered by PM3-relevant evidence first. Reviewed source only indicates whether main text, supplementary material, or both were reviewed; it is not the evidence conclusion.
| Gene | Variant | Evidence | PM3 context | Publication | Reviewed source | Actions |
|---|---|---|---|---|---|---|
| TTN |
NM_001267550.2:c.95234T>G
|
Phase-confirmed PM3 evidence
High confidence
|
Confirmed in trans with c.29024C > A; p.Ser9675*
context: Confirmed in trans
|
39277846
Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease.
Human molecular genetics, 2024
|
Main article | |
| LRP4 |
NM_002334.4:c.3830G>A
|
Phase-confirmed PM3 evidence
Not assessed
|
No PM3 candidate genotype identified
context: Confirmed in trans
|
24234652
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Human molecular genetics, 2014
|
Main article | |
| DNAH11 |
NM_001277115.2:c.7772C>T
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.8698C>T; p.Arg2900Ter
context: Compound heterozygous candidate
|
39536325
Uplift of genetic diagnosis of rare respiratory disease using airway epithelium transcriptome analysis.
Human molecular genetics, 2025
|
Main article | |
| TTN |
NM_001267550.2:c.51377A>G
|
Phase-unconfirmed biallelic evidence
High confidence
|
Confirmed in trans with c.31426 + 1G > C; splice donor
context: Confirmed in trans
|
39277846
Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease.
Human molecular genetics, 2024
|
Main article | |
| CFH |
NM_000186.4:c.1198C>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.3148A>T; p.Asn1050Tyr
context: Compound heterozygous candidate
|
34508573
Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene.
Human molecular genetics, 2022
|
Main article | |
| CFH |
NM_000186.4:c.3130A>G
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.3148A>T; p.Asn1050Tyr
context: Compound heterozygous candidate
|
34508573
Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene.
Human molecular genetics, 2022
|
Main article | |
| CFH |
NM_000186.4:c.481G>T
|
Phase-unconfirmed biallelic evidence
High confidence
|
Confirmed in trans with c.2850G>T; p.Gln950His
context: Confirmed in trans
|
34508573
Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene.
Human molecular genetics, 2022
|
Main article | |
| AARS1 |
NM_001605.3:c.2176A>G
|
Phase-unconfirmed biallelic evidence
High confidence
|
Confirmed in trans with c.2267C > T; p.Thr756Ile
context: Confirmed in trans
|
33909043
Protein instability associated with AARS1 and MARS1 mutations causes trichothiodystrophy.
Human molecular genetics, 2021
|
Main article | |
| AARS1 |
NM_001605.3:c.2267C>T
|
Phase-unconfirmed biallelic evidence
High confidence
|
Confirmed in trans with c.2176A > G; p.Thr726Ala
context: Confirmed in trans
|
33909043
Protein instability associated with AARS1 and MARS1 mutations causes trichothiodystrophy.
Human molecular genetics, 2021
|
Main article | |
| TNFRSF13B |
NM_012452.3:c.706G>T
|
Phase-unconfirmed biallelic evidence
Needs review
|
Possible compound heterozygous with A181V
context: Compound heterozygous candidate
|
33751038
Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.
Human molecular genetics, 2021
|
Supplementary material | |
| SLC38A8 |
NM_001080442.3:c.682G>C
|
Phase-unconfirmed biallelic evidence
Low confidence
|
Possible compound heterozygous with c.644G > T; c.695A > G; His232Arg; +1 more
context: Compound heterozygous candidate
|
32744312
SLC38A8 mutations result in arrested retinal development with loss of cone photoreceptor specialization.
Human molecular genetics, 2020
|
Main article | |
| HGSNAT |
NM_152419.3:c.1209G>T
|
Phase-unconfirmed biallelic evidence
Needs review
|
Possible compound heterozygous with p.A615T
context: Compound heterozygous candidate
|
25859010
Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT).
Human molecular genetics, 2015
|
Main article | |
| AHI1 |
NM_001134831.2:c.3263_3264del
|
Phase-unconfirmed biallelic evidence
Not assessed
|
Homozygous for query variant
context: Homozygous evidence
|
25616960
Non-manifesting AHI1 truncations indicate localized loss-of-function tolerance in a severe Mendelian disease gene.
Human molecular genetics, 2015
|
Main article | |
| FRAS1 |
NM_025074.7:c.5205C>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1918C>T; p.640R>C
context: Compound heterozygous candidate
|
24476948
Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound.
Human molecular genetics, 2014
|
Main article | |
| LRP4 |
NM_002334.4:c.3697G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Confirmed in trans with c.3830G > A; RH mutation; p.Arg1277His
context: Confirmed in trans
|
24234652
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Human molecular genetics, 2014
|
Main article | |
| COL11A2 |
NM_080680.3:c.388C>T
|
Other Patient-Level Evidence
Needs review
|
Patient-level evidence found, not PM3
context: Other patient-level evidence
|
37462524
COL11A2 as a candidate gene for vertebral malformations and congenital scoliosis.
Human molecular genetics, 2023
|
Main article | |
| DNAJB2 |
NM_006736.6:c.184C>T
|
Other Patient-Level Evidence
High confidence
|
No PM3 candidate genotype identified |
37070754
Extension of the DNAJB2a isoform in a dominant neuromyopathy family.
Human molecular genetics, 2023
|
Main article | |
| SDHA |
NM_004168.4:c.1157C>T
|
Other Patient-Level Evidence
High confidence
|
Patient-level evidence found, not PM3
context: Other patient-level evidence
|
36905328
Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan.
Human molecular genetics, 2023
|
Main article and supplement | |
| RYR1 |
NM_000540.3:c.14693T>C
|
Other Patient-Level Evidence
High confidence
|
Patient-level evidence found, not PM3
context: Other patient-level evidence
|
29701772
Inositol trisphosphate receptor-mediated Ca2+ signalling stimulates mitochondrial function and gene expression in core myopathy patients.
Human molecular genetics, 2018
|
Main article | |
| ANK3 |
NM_020987.5:c.3139G>A
|
Other Patient-Level Evidence
High confidence
|
Patient-level evidence found, not PM3
context: Other patient-level evidence
|
24463883
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.
Human molecular genetics, 2014
|
Supplementary material | |